Twitxy
Saved
@Airfinity's profile picture
View on X

Airfinity

@Airfinity

Airfinity tracks, simulates, and predicts population level disease outcomes in real time to inform decisions that can increase the global lifespan.
London, England airfinity.com Joined October 2016
862 Following 1.8K Followers 824 Posts

Latest posts 5

Airfinity @Airfinity
Watch our webinar: Countermeasure strategies to prevent an avian influenza pandemic here: youtu.be/QSDLvCuFOxo?si…
Maeve Cullinan Verified account @maeve_cullinan Oct 10, 2024
⁦@Airfinity⁩ predicts the risk of H5N1 & seasonal influenza reassortment will increase five-fold this winter… experts urging US to consider vaccines for poultry/dairy workers telegraph.co.uk/global-health/…
View quoted post on X
Airfinity @Airfinity
The cost of #Wegovy to prevent one stroke in the US is double what’s paid by Britain’s health service, reveals new analysis by Airfinity.

Read our feature in @Bloomberg to find out more.

bloomberg.com/news/articles/…
www.bloomberg.com Novo’s Wegovy Price Tag for Stroke Prevention Is Higher in US Novo Nordisk A/S’s obesity shot Wegovy also prevents strokes, heart attacks and death. The price of those benefits is far higher in the US, where the cost of the drug has prompted a political outcry.
Airfinity @Airfinity
As featured in the @FT today, Airfinity has reduced its sales projections for vaccines against Respiratory Syncytial Virus (#RSV) for older adults in the US from $4.7bn per year to $1.7bn by 2030.

Reach out to find out more about our estimate or the burden of RSV.
Financial Times Verified account @FT Jul 24, 2024
GSK, Pfizer and Moderna face RSV vaccine sales slump on.ft.com/4frIn7k
View quoted post on X